Babcock International Group (LON:BAB) Issues Quarterly Earnings Results

by · The Cerbat Gem

Babcock International Group (LON:BABGet Free Report) posted its earnings results on Monday. The company reported GBX 42.10 earnings per share for the quarter, Digital Look Earnings reports. Babcock International Group had a return on equity of 43.22% and a net margin of 5.79%.The company had revenue of GBX 517.77 billion during the quarter.

Here are the key takeaways from Babcock International Group’s conference call:

  • Babcock reported strong FY 2026 underlying performance, with organic revenue growth of 8%, operating margin up 70 bps to 8.2%, operating profit up 19% to £433 million, and EPS up 20%.
  • The company took a £140 million charge on the Type 31 frigate program after rework and productivity issues, although management said the cash impact is spread over the remaining life of the contract and absorbed within guidance.
  • Cash generation remained strong, with 84% cash conversion and free cash flow of £262 million, supporting a strong balance sheet and continued shareholder returns, including another £200 million buyback in FY 2027 and a 15% dividend increase.
  • All major sectors improved, led by Nuclear and supported by Marine and Aviation, while Land saw mixed results due to weaker civil activities; management said Nuclear already exceeds its 9% margin target and the group remains on track toward 9%+ medium-term margins.
  • New CEO Harry Holt outlined a strategy centered on defense, civil nuclear, hybrid warfare, warfighting readiness, and national strategic resilience, while emphasizing capital discipline and a smooth leadership transition.

Babcock International Group Stock Performance

LON:BAB opened at GBX 1,005 on Tuesday. The stock’s 50-day simple moving average is GBX 1,085.11 and its 200 day simple moving average is GBX 1,247.85. The firm has a market capitalization of £4.92 billion, a PE ratio of 18.01, a price-to-earnings-growth ratio of 1.35 and a beta of 0.89. The company has a quick ratio of 0.76, a current ratio of 0.82 and a debt-to-equity ratio of 147.82. Babcock International Group has a twelve month low of GBX 934.76 and a twelve month high of GBX 1,527.

Key Babcock International Group News

Here are the key news stories impacting Babcock International Group this week:

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Jefferies Financial Group restated a “buy” rating and set a GBX 1,400 target price on shares of Babcock International Group in a research report on Monday. JPMorgan Chase & Co. cut their price target on Babcock International Group from GBX 1,700 to GBX 1,500 and set an “overweight” rating for the company in a research note on Thursday, May 14th. Royal Bank Of Canada increased their price target on Babcock International Group from GBX 1,280 to GBX 1,400 and gave the stock an “outperform” rating in a research report on Friday, May 15th. Finally, Citigroup raised Babcock International Group to a “buy” rating and set a GBX 1,554 price objective for the company in a report on Wednesday, April 1st. Five research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of GBX 1,504.80.

View Our Latest Analysis on BAB

About Babcock International Group

(Get Free Report)

Babcock International Group PLC, together with its subsidiaries, provides value-add services for aerospace, defense, and security in the United Kingdom, rest of Europe, Africa, North America, Australasia, and internationally. The company operates through four segments: Marine, Nuclear, Land, and Aviation. It designs, procures, operates, and manages critical utility and process equipment; offers asset management, defense and maritime training, information and intelligence, equipment and system, and facilities and infrastructure services, as well as naval platforms; and designs, manufactures, and provides through-life support for mechanical and electrical systems and equipment.

Recommended Stories